Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06764485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

Study acronym: rechARge
StatusActive, Not Recruiting
PhasePhase 3
SponsorCelgene
Started2025-03-13
View on ClinicalTrials.gov ↗

Amendment history

2026-09-04
Study Status, Contacts/Locations v25
Trial sites expanded: 212 → 227 locations
Enrollment closed, study ongoing
Trial sites reduced: 281 → 212 locations
2026-08-17
Study Status, Contacts/Locations v24
Study sites281 entries, revised
QEIILocal Health Sciences CentreInstitution - Victoria0151 Local General Site CIUSSS- saguenay-Lac-Saint-Jean Hospital Universitario Reina Sofia Hospital Universitari Vall d'Hebron Hospital Universitari Parc Tauli OSI Ezkerraldea-Enkarterri-CrucesInstitution - Hospital0093 Local UniversitarioInstitution Cruces- 0312 HospitalLocal deInstitution la- Santa0310 Local CreuInstitution i- Sant0311 Local PauInstitution - 0325 HospitalLocal LucusInstitution Augusti- 0315 HospitalLocal GeneralInstitution Universitario- Gregorio0319 Local MarañonInstitution - 0321 HospitalLocal UniversitarioInstitution R [...] [...]
2026-07-21
Study Status, Contacts/Locations v23
Study sites282→281
2026-06-25
Study Status, Contacts/Locations v22
Study sites282 entries, revised
LocalHuizhou InstitutionCentral -People's 0415Hospital Institut de cancérologieCHU Strasbourg Europe (ICANS)-Hautepierre
2026-05-01
Study Status, Contacts/Locations, IPDSharing, References v21
Trial sites expanded: 279 → 282 locations
Publications1 to 3 entries
Rathkopf DE, Patel MR, Choudhury AD, Rasco D, Lakhani N, Hawley JE, Srinivas S, Aparicio A, Narayan V, Runcie KD, Emamekhoo H, Reichert ZR, Nguyen MH, Wells AL, Kandimalla R, Liu C, Suryawanshi S, Han J, Wu J, Arora VK, Pourdehnad M, Armstrong AJ. Safety and clinical activity of BMS-986365 (CC-94676 [...]
Show 20 earlier versions
2026-01-27
Study Status, Contacts/Locations v20
Study sites270→279
2026-01-09
Study Status, Contacts/Locations v19
Study sites270 entries, revised
LocalRocky InstitutionMountain -Regional 0238VA Medical Center
2026-01-08
Study Status, Contacts/Locations v18
Study sites269→270
2026-01-06
Study Status, Contacts/Locations v17
Study sites258→269
2025-12-01
Study Status, Contacts/Locations v16
Study sites258 entries, revised
LocalHollings InstitutionCancer Center Medical College of Wisconsin Hospital Privado Universitario de Córdoba Greenslopes Private Hospital - 0055 Local Institution - 0112 Local Institution - 0430 Gallipoli Medical Research Foundation LocalHospital InstitutionSírio -Libanês Peking 0395University First Hospital LocalGustave Institution - 0192 Local Institution - 0179Roussy
2025-11-04
Study Status, Contacts/Locations v15
Study sites258 entries, revised
LocalNorthwestern Institution - 0048 Greenslopes PrivateMemorial Hospital - Gallipoli Medical Research Hospital FoundationMoinhos de Vento Local Institution - 0026 Local Institution - 0381MILAB
2025-10-08
Study Identification, Study Status, Contacts/Locations v14
Study sites256→258
2025-09-22
Study Status, Contacts/Locations v13
Study sites250→256
2025-09-11
Study Status, Contacts/Locations v12
Study sites250 entries, revised
LocalChesapeake InstitutionUrology James M Stockman Cancer Institute Jewish General Hospital Second Affiliated hospital of Anhui Medical University Sun Yat-sen 0054University Cancer Center LocalGuangzhou InstitutionFirst -People's 0344Hospital LocalNanjing InstitutionDrum -Tower 0149Hospital The Affiliated Hospital of Nanjing University Medical School LocalZhongda InstitutionHospital -Southeast 0232University LocalShandong InstitutionCancer -Hospital Yantai 0226Yuhuangding Hospital LocalFudan InstitutionUniversity -Shanghai 0180Cancer Center LocalWest InstitutionChina -Hospital, 0233Sichuan Un [...] [...]
2025-08-22
Study Status, Contacts/Locations v11
Study sites248→250
2025-07-23
Study Status, Contacts/Locations v10
Study sites247→248
2025-06-30
Study Status, Contacts/Locations v9
Study sites245→247
2025-06-16
Study Status, Contacts/Locations v8
Study sites239→245
2025-05-28
Study Status, Contacts/Locations v7
Study sites238→239
2025-05-08
Study Status, Contacts/Locations v6
Study sites238 entries, revised
LocalMoores InstitutionCancer -Center University 0015of New Mexico Comprehensive Cancer Center LocalFox InstitutionChase -Cancer 0081Center LocalNorthwest InstitutionCancer -Specialists, 0057P.C. LocalSt. InstitutionJohn -of 0293God Murdoch Hospital LocalChina InstitutionMedical -University 0357Hospital LocalThe InstitutionChristie -NHS 0398 LocalFoundation Institution - 0248Trust
2025-04-28
Study Status, Contacts/Locations v5
Study sites237→238
2025-04-09
Study Status, Contacts/Locations v4
Study sites234→237
2025-03-14
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations, References v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-03-11→confirmed 2025-03-13
Study sites232→234
2025-01-28
Study Status, Contacts/Locations v2
Study sites230→232
2025-01-10
Study Status, Contacts/Locations v1
Study sitesdetails revised at 2 of 230 sites
2025-01-02
Original filing
The purpose of this study is to compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate Cancer.
Trial Details
NCT Number NCT06764485
Lead Sponsor Celgene
Conditions Metastatic Castration-resistant Prostate Cancer
Enrollment 960 participants
Start Date 2025-03-13
Primary Completion 2027-09-12 (estimated)
Study Completion 2029-01-19 (estimated)
Updated on ClinicalTrials.gov 2026-09-30